Top compounds associated with response to CNFN


Feature Type Standardized
Nominal ANOVA
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.057 0.3
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.055 0.3
mRNA PFI-1 GDSC1000 pan-cancer AAC -0.038 0.3
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA TPCA-1 GDSC1000 pan-cancer AAC -0.033 0.3
mRNA masitinib CTRPv2 pan-cancer AAC -0.04 0.3
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA lapatinib UHNBreast pan-cancer AAC -0.32 0.3
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
Download CSV